Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Melittin (TFA)

Melittin TFA is a PLA2 activator, stimulates the activity of the low molecular weight PLA2, while it does not the increase activity of the high molecular weight PLA2[1][2].

Product Specifications

UNSPSC

12352209

Target

Phospholipase

Type

Peptides

Related Pathways

Metabolic Enzyme/Protease

Applications

Metabolism-sugar/lipid metabolism

Field of Research

Cancer; Infection

Assay Protocol

https://www.medchemexpress.com/melittin-tfa.html

Purity

99.17

Solubility

H2O : ≥ 50 mg/mL

Smiles

NC(CC[C@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CC1=CNC2=CC=CC=C12)NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H]3N(C([C@@H](NC(CNC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@@H](NC(CN)=O)[C@H](CC)C)=O)=O)C)=O)C(C)C)=O)CC(C)C)=O)CCCCN)=O)C(C)C)=O)CC(C)C)=O)[C@@H](C)O)=O)[C@@H](C)O)=O)=O)CC(C)C)=O)CCC3)=O)C)=O)CC(C)C)=O)[C@H](CC)C)=O)CO)=O)=O)[C@H](CC)C)=O)CCCCN)=O)CCCNC(N)=N)=O)CCCCN)=O)CCCNC(N)=N)=O)CCC(N)=O)=O)C(N)=O)=O.OC(C(F)(F)F)=O

Molecular Formula

C132H230F3N39O33

Molecular Weight

2960.48

References & Citations

[1]Steiner MR, et al. Responses of purified phospholipases A2 to phospholipase A2 activating protein (PLAP) and Melittin. Biochim Biophys Acta. 1993 Feb 10;1166 (1) :124-30.|[2]Alonezi S, et al. Metabolomic Profiling of the Effects of Melittin on Cisplatin Resistant and Cisplatin Sensitive Ovarian Cancer Cells Using Mass Spectrometry and Biolog Microarray Technology. Metabolites. 2016 Oct 13;6 (4) . pii: E35.

Shipping Conditions

Blue Ice

Storage Conditions

-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)

Scientific Category

Peptides

Clinical Information

No Development Reported

Citation 01

Free Radic Res. 2022 May-Jun;56 (5-6) :398-410.|Adv Healthc Mater. 2025 Apr;14 (9) :e2400543.|Cancer Lett. 2022 May 28;534:215615.|Cell Rep Med. 2025 Aug 19;6 (8) :102254.|FASEB J. 2020 Nov;34 (11) :14892-14904.|Front Microbiol. 2020 Jul 31:11:1720.|Heliyon. 2024 Jan 6;10 (1) :e24239.|J Appl Microbiol. 2024 Jan 2;135 (1) :lxae001.|J Chromatogr A. 2025 Nov 22:1763:466460.|J Exp Med. 2022 May 2;219 (5) :e20212414.|J Integr Med. 2023 Jan;21 (1) :106-115.|J Pharm Pharmacol. 2023 Apr 17;75 (5) :645-654.|PeerJ. 2018 Jul 25:6:e5369.|Phytomedicine. 2025 Jan 2:137:156367.|Prostate. 2023 Nov;83 (15) :1430-1445.

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

CDC25A (M-phase Inducer Phosphatase 1, Dual Specificity Phosphatase Cdc25A) APC
MBS6468413-01 0.1 mL

CDC25A (M-phase Inducer Phosphatase 1, Dual Specificity Phosphatase Cdc25A) APC

Ask
View Details
CDC25A (M-phase Inducer Phosphatase 1, Dual Specificity Phosphatase Cdc25A) APC
MBS6468413-02 5x 0.1 mL

CDC25A (M-phase Inducer Phosphatase 1, Dual Specificity Phosphatase Cdc25A) APC

Ask
View Details
JAK2 Antibody
ASA-B1085 1 Each

JAK2 Antibody

Ask
View Details
Ros1 Protein (N-GST, Human)
P528151 100 µg

Ros1 Protein (N-GST, Human)

Ask
View Details
TJP1 Antibody, Biotin conjugated
A36642-50UL 50 μL

TJP1 Antibody, Biotin conjugated

Ask
View Details
Tissue, Section, Human Tumor, Lymph Nodes Tumor, Reactive Hyperplasia of Lymph Node (Paraffin)
MBS639985-01 5 Sections

Tissue, Section, Human Tumor, Lymph Nodes Tumor, Reactive Hyperplasia of Lymph Node (Paraffin)

Ask
View Details